REFERENCES
- Brunelli S, Lewis J, Gupta M. Risk of kidney injury following use of oral phosphosoda bowel preparations. J Am Soc Nephrol. 2007;18(12):3199–3205.
- Aydogan T, Kanbay M, Uz B, . Fatal hyperphosphatemia secondary to a phosphosoda bowel preparation in a geriatric patient with normal renal function. J Clin Gastroenterol. 2006;40(2):177.
- Gumurdulu Y, Serin E, Ozer B, Gokcel A, Boyacioglu S. Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation. J Gastroenterol Hepatol. 2004;19(1):68–72.
- Khurana A, McLean L, Atkinson S, Foulks C. The effect of oral sodium phosphate drug products on renal function in adults undergoing bowel endoscopy. Arch Intern Med. 2008;168(6):593–597.
- Markowitz G, Stokes M, Radhakrishnan J, D’Agati V. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: An underrecognized cause of chronic renal failure.J Am Soc Nephrol. 2005;16(11):3389–3396.
- Desmeules S, Gergeron M, Isenring P. Acute phosphate nephropathy and renal failure. N Engl J Med. 2003;349(10):1006–1007.
- Markowitz G, Nasr S, Klein P, . Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing. Hum Pathol. 2004;35(6):675–684.
- Fine A, Patterson J. Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: Two cases and a review of the literature. Am J Kidney Dis. 1997;29(1):103–105.